Two of the four cases are in Lubbock, which hasn’t seen a case in more than 20 years. Meanwhile, measles vaccination rates in ...

Maze Therapeutics said on Thursday that it raised $140 million in an initial public offering, setting the stage for a debut that will make the kidney disease drug developer the first U.S. biotech ...

The hearings were packed to capacity with protesters and fans, while the spillover crowd hung out in hallways and overflow ...